You are here

Category
Technology Name
Briefcase
Scientist
1671
A novel method to revert human iPSC to a fully naive state, retaining stable pluripotency. The feasibility for the existence of ground state naive pluripotency in human embryonic stem cells (hESC) has long been researched. This innovative technology supplies the composition of chemically defined...

A novel method to revert human iPSC to a fully naive state, retaining stable pluripotency. The feasibility for the existence of ground state naive pluripotency in human embryonic stem cells (hESC) has long been researched. This innovative technology supplies the composition of chemically defined conditions required for derivation and long term maintenance of such cells, without genetic modification.
Human naive pluripotent cells can be robustly derived either from already established conventional hESC lines, through iPSC reprogramming of somatic cells, or directly from ICM of human blastocysts. The new human pluripotent state was isolated and characterized; it can open up new avenues for patient specific disease relevant research and the study of early human development.

Applications


  • Reprogramming kits - Somatic cells to iPSC at near 100% efficiency (7days), iPSC to fully naive state.

Advantages


  • Deterministic iPSC reprogramming with no genetic modification required.
  • Stable pluripotency, with low propensity for differentiation
  • Reagents available off-the-shelf.

Technology's Essence


Hallmark features of rodent naive pluripotency include driving Oct4expression by its distal enhancer, retaining a pre-inactivation state of X chromosome in female pluripotent cell lines amongst others. Naive mouse ESCs epigenetically drift towards a primed pluripotent state; while human embryonic stem cells (hESCs) share several molecular features with naive mESCs (e.g. expression of NANOG, PRDM14 and KLF4 naive pluripotency promoting factors), they also share a variety of epigenetic properties with primed murine Epiblast stem cells (mEpiSCs). These observations have raised the question of whether conventioal human ESCs and induced pluripotent stem cells (iPSCs) can be epigenetically reprogrammed into a different pluripotent state, extensively similar with rodent na?ve pluripotency. Researchers at the Weizmann Institute discovered that supplementation of certain chemically defined conditions, synergistically facilitates the isolation and maintenance of pluripotent stem cells that retain growth characteristics, molecular circuits, a chromatin landscape, and signaling pathway dependence that are highly similar to naive mESCs, and drastically distinct from conventional hESCs.

+
  • Dr. Jacob (Yaqub) Hanna
1749
Our novel technology provides an inexpensive, safe and clean solution for loading and unloading of hydrogen on demand with high potential hydrogen storage capacity. Hydrogen storage is currently the key hurdle to its utilization as an alternative green fuel. Being the smallest molecule, hydrogen is...

Our novel technology provides an inexpensive, safe and clean solution for loading and unloading of hydrogen on demand with high potential hydrogen storage capacity.
Hydrogen storage is currently the key hurdle to its utilization as an alternative green fuel. Being the smallest molecule, hydrogen is highly diffusive and buoyant. Currently, hydrogen is stored physically as a gas, requiring high-pressure tanks, or in liquid form at cryogenic temperatures, both methods require high energy input. Proposed chemical storage systems are based on relatively expensive materials, suffer from poor regeneration after hydrogen release and require elevated temperatures and pressures.
The presented technology utilizes inexpensive and abundant organic compounds that generate hydrogen gas during a chemical transformation. Hydrogen release and the regeneration of the original compound are performed in mild conditions using the same catalyst. This system is a promising candidate to be the basis of compact and cost-effective chemical hydrogen storage platforms.

Applications


  • High potential hydrogen storage capacity (6.6 wt%)
  • Inexpensive and readily available hydrogen carriers (aminoalcohols)
  • Relatively mild release and regeneration conditions

  • Advantages


    • Hydrogen-fueled systems, including fuel cells
    • High capacity hydrogen storage systems

    Technology's Essence


    The technology is based on aminoalcohols that are catalytically converted to cyclic dipeptides, while forming hydrogen gas, using a ruthenium pincer catalyst. Peptide hydrogenation, using the same catalyst, regenerates the aminoalcohol. The same method can be applied with diaminoalkanes and alcohols as well.
    The reaction requires a relatively low organic solvent volume, a catalytic amount of base (KOtBu) for the in situ generation of the active catalyst and mild reaction conditions in terms of hydrogen pressure (50 bar) and temperature (~100 oC). Repetitive cycles of the dehydrogenation-hydrogenation reactions can be performed without adding new catalyst, while maintaining high percentages of aminoalcohol conversion.

    +
    • Prof. David Milstein
    1704
    Neuropathic Gaucher’s (nGD), is a rare but very severe manifestation of the disease, with a varying degree of involvement of the central nervous system, in addition to systemic symptoms. As of today, there is no cure for these severe conditions. The search for such cure is tremendously hindered by the...

    Neuropathic Gaucher’s (nGD), is a rare but very severe manifestation of the disease, with a varying degree of involvement of the central nervous system, in addition to systemic symptoms. As of today, there is no cure for these severe conditions.
    The search for such cure is tremendously hindered by the unmet need for a reliable biochemical biomarker for nGD.
    The present invention identifies the glycoprotein non-metastatic B (GPNMB) as a potential powerful nGD biomarker for use in early diagnosis, determination of disease severity, as well as a straight forward readout in clinical and preclinical experiments.

    Applications


    Diagnosis and drug development for neuropathic GD

    Advantages


    Straight forward diagnostic tool – based on standard biochemical assays
    Relatively simple clinical procedure – samples are collected from CSF and not brain
    High sensitivity – for the diagnosis of disease severity
    Compatible with preclinical experiments

    Technology's Essence


    Prof. Futerman and his team preformed a quantitative global proteomic analysis (using LC-MS/MS) of cerebrospinal fluid (CSF) samples from four patients with Type 3 GD, to identify mis-regulated proteins, compared with healthy subject.
    Glycoprotein non-metastatic B (GPNMB), a protein that was previously associated with several lysosomal storage disorders, exhibited very high levels (a 42-fold increase) in the CSF of type 3 GD patients.  Two peptides were identified from GPNMB, both located in the non-cytosolic domain, suggesting that GPNMB is cleaved and secreted into the CSF from the brain. LC-MS/MS results were validated by ELISA and by western blot analysis in CSF and in human brain samples.
    Several proof of principle experiments were conducted in order to prove the validity of using GPNMB as a biomarker for monitoring disease state and treatments efficacy in neuropathic GD in patients and mouse models:
    GPNMB levels were shown to be correlated with the severity of type 3 Gaucher’s disease patients, as measured by lower IQ score and lower score in Purdue Pegboard test, assessing eye-hand coordination. In addition, using conduritol b epoxide (CBE)-injection based mouse model that simulate different severities and recovery periods, it was shown that GPNMB levels rapidly rise or decline to reliably reflect progress/remission states of the diseases.

    +
    • Prof. Anthony H. Futerman
    1715
    Preparation of Re-doped inorganic MoS2 nanoparticles with good sodium ion reversible intercalation properties, to be used as cathode material for next generation sodium ion batteries. Lithium ion batteries (LIB) are currently the leading energy storage solution used in many applications. But lithium is...

    Preparation of Re-doped inorganic MoS2 nanoparticles with good sodium ion reversible intercalation properties, to be used as cathode material for next generation sodium ion batteries.
    Lithium ion batteries (LIB) are currently the leading energy storage solution used in many applications. But lithium is both toxic and limited in quantity (hence expensive) and cannot supply the growing demand for energy storage units as well as the need for cleaner and safer technologies.
    Sodium ion batteries (SIB) are attractive new generation batteries as they incorporate the much less toxic and much more abundant sodium ion.
    Our novel nanoparticles were shown to have competitive electrochemical performances with specific capacity of about 130 mAh/g at 2C and 74 mAh/g at high discharge rate of 20C.

    Applications


    • Electrode material for sodium ion batteries
    • Possible applications in magnesium ion batteries

    Advantages


    • Competitive specific capacity
    • Improved electrical conductivity towards Na ions

    Technology's Essence


    The cathode material's reversible intercalation capacity plays a significant role in determining the total capacity of an energy cell. Intercalation requires entering of ions into the electrode material through diffusion channels.
    The faceted structure of inorganic nanoparticles (IF) induces intrinsic dislocations and stacking faults which serve as ion diffusion channels. Doping of the nanoparticles increases both conductivity, due to n-type doping of the Mo metal, and the number of structural defects (hence diffusion channels), resulting in total increased electrical conductivity.
    The synthetic procedure for producing Re-doped MoS2 nanoparticles is straightforward, based on known and published protocols.

    +
    • Prof. Reshef Tenne
    1782
    L-DOPA is a high value compound used in the treatment of Parkinson’s disease and a precursor for other high value compounds. Current industrial methods for producing L-DOPA are problematic in terms of complexity, yield, or toxic byproducts.Betalains are robust, flavorless, natural water soluble dyes,...

    L-DOPA is a high value compound used in the treatment of Parkinson’s disease and a precursor for other high value compounds. Current industrial methods for producing L-DOPA are problematic in terms of complexity, yield, or toxic byproducts.
    Betalains are robust, flavorless, natural water soluble dyes, in the color ranges of both red-violet and yellow-orange. Currently there is no natural quality source for water soluble natural yellow dyes, with present natural yellow dyes being water insoluble.
    The present technology offers an alternative method that is simple, does not produce side-products, and is non-toxic with Tyrosine being the only feedstock. The technology produces L-DOPA and natural water soluble yellow and red Betalain dyes, both within yeast and in different plant species.

    Applications


    • Production of L-DOPA for use in pharmaceuticals or dietary supplements.
    • Synthesis of water soluble yellow and red natural dyes for use as colorants, antioxidants, and food supplements.
    • Altering coloration of ornamental plants by inserting the metabolic pathway.

    Advantages


    • One-step reaction for L-DOPA synthesis from Tyrosine.
    • Non-toxic and non-hazardous synthesis.
    • Ecologically friendly - no waste management issues.
    • Multiple colors can be produced with yellow, red, or orange if pathways combined.
    • Flavorless - avoid influencing the taste of different products.
    • Flexibility in biosynthetic production - multiple possible host systems.
    • Specificity - no side products produced
    • Mild Conditions - enzyme(s) requires ambient temperatures.

    Technology's Essence


    The present technology takes advantage of the Betalain biosynthetic pathway to selectively produce L-DOPA and natural Betalain dyes. A newly discovered, specific, cytochrome P450-CYP76AD6 begins the pathway, with the capacity to convert Tyrosine to L-DOPA. Then L-DOPA is converted to Betalamic acid via DOPA 4, 5-dioxygenase.
    With the Betalamic acid intermediate, the biosynthetic pathway diverges to make either Betaxanthins (yellow dyes) or Betacyanins (red dyes). In the production of yellow dyes an amine (e.g. amino acid) spontaneously reacts with Betalamic acid. In the case of red dyes, cycloDOPA (generated by the enzyme CYP76AD1 modifying Tyrosine and L-DOPA) and a Betalain-related glucosyltransferase react with Betalamic acid. Furthermore the two pathways can be done in parallel to produce an orange color.

     

    +
    • Prof. Asaph Aharoni
    1676
    A novel renewable energy method for storage of concentrated solar power (CSP) thermal energy directly to electrochemical energy that can be used for for distribution.A crucial issue for CSP technologies today is providing energy capable of dispatchable generation, that is, sources of electricity whose...

    A novel renewable energy method for storage of concentrated solar power (CSP) thermal energy directly to electrochemical energy that can be used for for distribution.
    A crucial issue for CSP technologies today is providing energy capable of dispatchable generation, that is, sources of electricity whose power load can be changed instantaneously with power demand. Further commercial deployment of CSP on a large scale depends on increase of the annual contribution of solar electricity, better coping with the intermittent nature of this resource and rapid integration with existing electrical distribution infrastructure, i.e. smart grids. 
    The technology presented here offers a unique solution to these problems while significantly reducing monetary and environmental costs associated with current CSP systems.
    Unlike conventional thermal CSP plants, the novel method does not require the use of a turbine to convert heat to electricity, and the electricity is directly obtained from the electrochemical cell during its discharge cycle. Moreover, this energy storage technique precludes the use of electric power generators (e.g. turbines, wind turbines, photovoltaic panels) which are often used to recharge electrochemical cells by applying electrical power to the cells' electrode terminals. This reduces expenses and eliminates inefficiencies of a traditional solar electrical plant.

    Applications


    • As modular stand-alone electrical plant for commercial or private use.
    • Integrate into existing power plants for load sharing.

    Advantages


    • Directly transform solar thermal energy into electrical potential energy.
    • Transport of large amounts of water in arid areas is not required.
    • Battery can change loading instantaneously for:
      - Use in smart grid and dispatchable generation
      - Easily Incorporated with other green energy solutions

    Technology's Essence


    This novel system utilizes a rechargeable thermochemical cycle based on Na-S battery technology. The innovation is the exploitation of concentrated solar radiation for thermo-chemical charging instead of electricity from photovoltaic or wind resources as done today. With this concept, a final efficiency of about 50% from solar to electricity can be achieved, which makes a monumental economic impact on existing CSP technologies. The sodium-sulfur battery discharge cycle usually works at temperatures ranging between 300 and 350oC, at which the sodium, sulfur and the reaction product of sodium polysulfide, Na2Sx (where x=3 to 5), exist in their liquid state. Charging of the battery is achieved at temperatures of 1500-1700 oC, when sodium polysulfide is fully decomposed and the full electrical potential of the battery is restored.[1] Instead of charging the Na-S Battery with an external source of electricity to decompose the sodium polysulfide compound back to its Na and S ingredients, it is proposed that the decomposition process will be achieved thermally via CSP.

    +
    • Mr. Michael Epstein
    1751
    Many cancer cells hijack and remodel existing metabolic pathways for their benefit. Specific targeting of these metabolic dependencies offers cancer patients increased efficiency and minimized side effects. Yet, the complexity of these pathways hinders the identification of targets. The present...

    Many cancer cells hijack and remodel existing metabolic pathways for their benefit. Specific targeting of these metabolic dependencies offers cancer patients increased efficiency and minimized side effects. Yet, the complexity of these pathways hinders the identification of targets.
    The present discovery elucidates the pathway by which argininosuccinate synthase (ASS1) down-regulation confer cancer progression. It shows that decreased activity of ASS1 in cancers supports proliferation by linking excess aspartate to pyrimidines synthesis. Importantly, these studies highlight Citrin (a mitochondrial aspartate transporter) inhibition as a potential method to decrease aspartate levels and selectively target this metabolic pathway in ASS1 depleted cancers.

    Applications


    • Targeted Treatment for ASS1 depleted cancers.

    Advantages


    • Targeted therapy, against a well defined pathway, increases the prospects for success.
    • Selective – targeting cancer metabolic dependency minimizes the chances for healthy cells damage that lead to side effects.

    Technology's Essence


    Cancer cells hijack and remodel existing metabolic pathways for their benefit in what is termed the Warburg effect. Researchers from Dr. Ayelet Erez's lab, at the Weizmann institute of Science, have delineated the metabolic benefit(s) conferred by loss of ASS1 to cancers. In agreement with previous experience, they found that ASS1 deficiency has an additional arginine- independent effect that is directly related to its substrate, aspartate.
    By focusing on the relevant physiological and pathological model systems, it was found that ASS1 deficiency-mediated increase in aspartate levels lead to excessive proliferation through pyrimidine synthesis. The link between the two is provided by CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, dihydroorotase complex) and the mTOR signaling pathway.
    Importantly, the present inventors have found that blocking Citrin, the mitochondrial aspartate transporter, rescues cell proliferation by reducing aspartate levels. Citrin may thus serve as a strong candidate for targeted therapy of ASS1 depleted cancers.   
    Supporting this model, retrospective survival analysis of several cancers reveal that cancers with both decreased ASS1 expression and high Citrin levels have a trend for significantly worse prognosis.

    +
    • Dr. Ayelet Erez
    1800
    A new software tool used for the removal of artifacts from transcranial magnetic stimulation (TMS) triggered electroencephalography (EEG) was developed by the group of Prof. Moses. The combined use of TMS with EEG allows for a unique measurement of the brain's global response to localized and abrupt...

    A new software tool used for the removal of artifacts from transcranial magnetic stimulation (TMS) triggered electroencephalography (EEG) was developed by the group of Prof. Moses.

    The combined use of TMS with EEG allows for a unique measurement of the brain's global response to localized and abrupt stimulations. This may allow TMS-EEG to be used as a diagnostic tool for various neurologic and psychiatric conditions.

    However, large electric artifacts are induced in the EEG by the TMS, which are unrelated to brain activity and obscure crucial stages of the brain's response. These artifacts are orders of magnitude larger than the physiological brain activity, and persist from a few to hundreds of milliseconds. However, no generally accepted algorithm is available that can remove the artifacts without unintentionally and significally altering physiological information.

    The software designed according to the model along with a friendly GUI is a powerful tool for the TMS-EEG field. The software has tested and proven to be effective on real datasets measured on psychiatric patients.

    Applications


    • TMS triggered EEG diagnostics

    Advantages


    • Easy to use software with a GUI
    • Exposes the full EEG from the brain

    Technology's Essence


    The new software tool is based on the observation that, contrary to expectation, the decay of the electrode voltage after the TMS pulse is a power law in time rather than an exponential. A model based on two dimensional diffusion of the accumulated charge from the high electric
    fields of the TMS in the skin was built. This model reproduces the artifact precisely, including the many perplexing artifact shapes that are seen on the different electrodes. Artifact removal software based on this model exposes the full EEG from the brain, as validated by continuously reconstructing 50Hz signals that are the same magnitude as the brain signals.

    +
    • Prof. Elisha Moses
    1712
    • Prof. Yechiel Shai
    1717
    Converting two low-energy photons into a single higher-energy photon is of significant importance in many fields. In medical imaging, photon up-conversion is used for imaging scattered specimens, while in photovoltaic devices it could be used to harvest photons with energies lower than the bandgap of...

    Converting two low-energy photons into a single higher-energy photon is of significant importance in many fields. In medical imaging, photon up-conversion is used for imaging scattered specimens, while in photovoltaic devices it could be used to harvest photons with energies lower than the bandgap of the absorber.
    Currently available systems, based on rare-earth-doped dielectrics, and organic materials are limited in both tunability and absorption cross-section. In fact, no known up-conversion systems operate on photons in the 1000-1500 nm range.
    Stable inorganic nanocrystalline up-conversion systems designed at the Weizmann Institute of Science provide broad tunability of both the absorption edge and the luminescence color. These materials have the potential to be utilized in applications such as high-energy photon sources, photovoltaics and IR detection.

    Applications


    • Easy to manufacture

    • Robust systems

    • Operation at room temperature


    Advantages


    • Photon sources

    • Photovoltaics

    • IR detectors


    Technology's Essence


    The new up-conversion systems are based on a novel design comprising a compound semiconductor nanocrystal, which incorporates two quantum dots with different bandgaps separated by a tunneling barrier. The expected up-conversion mechanism occurs by the sequential absorption of two photons. The first photon excites an electron–hole pair by interband absorption in the lower-energy core, resulting in a confined hole and a relatively delocalized electron. The second absorbed photon leads to further excitation of the hole, allowing it to cross the barrier layer. This, in turn, is followed by radiative recombination with the delocalized electron.

    +
    • Prof. Dan Oron
    1684
    Gaseous energy sources such as hydrogen and natural gas (predominantly methane) encompass an intrinsic transport problem because of their volatility and flammability. Adsorption of the gas on a solid material (such as MOF) facilitates safe, light and economical transport of the gas. This is especially...

    Gaseous energy sources such as hydrogen and natural gas (predominantly methane) encompass an intrinsic transport problem because of their volatility and flammability. Adsorption of the gas on a solid material (such as MOF) facilitates safe, light and economical transport of the gas. This is especially significant in the huge natural gas (NG) market where solutions are required for storage and transport of the gas whether from NG reservoirs in high pressure giant tanks or as a compact low pressure NG tank for small vehicles and other NG powered devices.
    The invention involves a new method for the formation of uniform metal organic frameworks (MOFs) at quantitative yields and in a controlled manner.
    These MOFs can be tailored to adsorb specific gases for low pressure - high volume storage and transport applications.

    Applications


    • Low pressure – high volume gas storage and transportation
    • Safe storage of toxic or otherwise dangerous gases
    • Low energy solid phase gas separation and purification
    • Production of MOF-based catalysts

    Advantages


    • Uniform crystallite morphology
    • A quantitative process
    • Ability to design and control product structure
    • Control of pore size
    • Single step process
    • No additives

    Technology's Essence


    The invention comprises a new solvothermal synthetic procedure in which specific metal ions are selected to react with specific organic ligands to form uniform sub-microstructured MOFs with a narrow size distribution and without the need for a modulator to define the crystal morphology.
    Controlling the selected reagents as well as the specific reaction conditions influences the resulting crystallites formed and enables a fine selection of the desired structure.
    MOFs prepared this way have exceptional uniformity profiles of size and shape and can be tailored to selectively adsorb specific gases for low pressure - high volume storage and transport applications.

    +
    • Prof. Milko E. Van der Boom
    1753
    The Chiral Induced Spin Selectivity (CISS) effect, discovered in recent years by Prof. Ron Naaman from the Weizmann Institute of Science, implies that electrons transferred through chiral molecules possess a specific spin orientation. Hence, the molecular chirality and electron spin are correlated.A...

    The Chiral Induced Spin Selectivity (CISS) effect, discovered in recent years by Prof. Ron Naaman from the Weizmann Institute of Science, implies that electrons transferred through chiral molecules possess a specific spin orientation. Hence, the molecular chirality and electron spin are correlated.
    A team of researchers lead by Prof. Naaman have been investigating the CISS effect in different systems. They found that the high efficiency of many natural multiple electron reactions can also be attributed to spin alignment of the electrons involved.
    The present innovation looks at hydrogen production through water electrolysis, showing that when using anodes coated by chiral molecules the efficiency of the electrolysis process increases by 30% compared to using uncoated, regular electrodes.

    Applications


  • Control of electron spin
  • Significant reduction of over-potential in spin sensitive electrochemical reactions
  • Efficient electrochemical processes
  • Minimum side reactions

  • Advantages


     

    Technology's Essence


    Spin selective electrodes made from standard electrode material are coated with chiral molecules. These coated electrodes were used for electrolysis of water and showed superior efficacy compared to standard un-coated electrodes, by reduction of the over-potential required for the process. This is explained by the spin selective electron conduction through the chiral layer:

     

     

     

    Hydrogen production as a function of time for (A) the chiral molecules and (B) for the achiral molecules. The potentials in the brackets refer to the over-potential compared to DNA coated electrode. The measurements were conducted at the Eapp for each of the molecules.

     

    +
    • Prof. Ron Naaman
    1664
    Neuroinflammation is well established as a key secondary injury mechanism following CNS trauma, such as traumatic brain/spinal injury or ischemic stroke, and it has been long considered to contribute to the damage sustained and fatal outcomes following brain injury. Early inflammatory events enhance...

    Neuroinflammation is well established as a key secondary injury mechanism following CNS trauma, such as traumatic brain/spinal injury or ischemic stroke, and it has been long considered to contribute to the damage sustained and fatal outcomes following brain injury.
    Early inflammatory events enhance brain damage, yet they provide the framework for later inflammatory events that enhance tissue remodeling and are crucial for tissue recovery.
    A major unmet need in the field is a targeted treatment that would down regulate the damaging events of inflammation, while maintaining reparative functions. 
    Altering between CNS microglia pro and anti-inflammatory activation states is at the core of injury-induced neuroinflammation and presents an opportunity to specifically tilt the balance towards anti-inflammatory and repair processes.
    The present discovery elucidates the mechanisms that lead to injury-induced microglia over-activation and proposes IFN-? as a therapeutic strategy to induce microglia resolving state and relive inflammation. 

    Applications


    Anti-inflammatory treatment following CNS injury

    Advantages


    • Targeted therapy – avoids general immuno-suppressive side effects
    • Based on a well understood molecular mechanism
    • May allow relatively large therapeutic window – according to proof-of-concept  preliminary experiments

    Technology's Essence


    Resident microglia are the major specialized innate immune cells of the central nervous system (CNS). During the process of wound healing or pathogen removal, there is an induction of the microglia active pro-inflammatiry phenotype (M1), leading to a transient inflammatory response, which is resolved via local conversion to the M2 anti-inflammatory phenotype.  Following acute injury, microglia fail to acquire an inflammation-resolving phenotype (M2-like phenotype) in a timely manner, often resulting in self-perpetuating local inflammation and tissue destruction beyond the primary insult.
    Prof. Schwartz and her team uncovered the mechanisms that lead to injury-based inhibition of the M1 to M2 phenotype switch.  They showed that the capacity to undergo pro- to anti-inflammatory (M1-to-M2) phenotype switch is controlled by the transcription factor Interferon regulatory factor-7 (IRF7).  Their results demonstrate that restoring Irf7 expression by IFN-? (a known IRF7 activator) reactivates the circuits leading to M2 conversion by improving the resolution of pro?inflammatory cytokines expressed by microglia ex vivo and in vivo, following acute CNS insult.
    Importantly, the anti-inflammatory activity of IFN-? was demonstrated in-vivo, when administrated 24h following the primary insult, proposing a relatively large therapeutic window.

    +
    • Prof. Michal Schwartz-Eisenbach
    1577
    A novel desulfurization system achieves removal of sulfur dioxide (SO2) from industrial exhaust streams at efficiencies that can greatly supersede technologies currently in use. The chemical process is highly selective to SO2, and consumes much less reagents, therefore reducing the cost of...

    A novel desulfurization system achieves removal of sulfur dioxide (SO2) from industrial exhaust streams at efficiencies that can greatly supersede technologies currently in use. The chemical process is highly selective to SO2, and consumes much less reagents, therefore reducing the cost of desulfurization.Techniques to capture SO2 from coal-burning plants have not changed in nearly 40 years. Once implemented, the technology presented here can become significantly more efficient and environmentally friendly than existing techniques, since no slurry waste is created from the wet sorbents typically used to capture SO2.The novel system can selectively recycle SO2 into useful sulfur-based compounds which can be resold; utilizing a carbonate eutectic melt this procedure can also be aimed to generate elemental sulfur, an inert and non-toxic compound which can be stored long-term until required for further use.In a world anxious over climate change, yet in demand of more energy, solutions should have the capacity to be implemented quickly and incorporated into existing infrastructure. This technology offers the potential to tackle several problems with one simple solution.

    Applications


    Integrate into industrial fossil-fuel burning facilities which include:

    • Power plants
    • Cement factories
    • Steel foundries

    Advantages


    • Implement into existing infrastructure and reduce reagents’ costs compared to current techniques
    • Significantly higher efficiency and elimination of hazardous waste by-products
    • Potential generation of revenue from recycled Sulfur waste.

    Technology's Essence


    The significant enhancement of this scrubbing technique is the sequentially operable scrubbing zone and regeneration zone, which communicate with one another via a molten eutectic mixture of lithium, sodium and potassium carbonates. In the scrubbing zone, an ingress flue gas interacts with the molten carbonates, resulting in chemical absorbance of the SO2 and in discharge of reaction gases. In the regeneration zone, either chemical or electrochemical melt regeneration takes place resulting in formation of sulfur containing vapor which is cooled down for converting the sulfur-containing vapor into a liquid and solid phase for a further collection and utilization.The technology developed by Prof. Igor Lubomirsky and his team introduces three essential improvements over past techniques: (i) the removal of sulfate from the melt is achieved at expected operating temperatures of an industrial scrubbing tower (480-550°C), which drastically reduces corrosion of metal components, (ii) the reduction of sulfates by CO gas rather than by carbon powder represents a simpler, one-step process, which results in a high reduction rate and allows for the reaction chamber to be small (few tens of m3 for a 1GW coal plant), and (iii) the removal of sulfate in the form of COS, rather than H2S, provides considerable freedom in choosing the final sulfur product – either sulfuric acid or elemental sulfur.

     

    +
    • Prof. Igor Lubomirsky
    1616
    Existing treatments against cancer are non-sufficiently selective. Immunotherapy based treatment offers highly selective and efficient solution to this problem. A promising approach in Immunotherapy is adoptive cell therapy (ACT). In ACT, therapeutic lymphocytes are administrated to patients in order...

    Existing treatments against cancer are non-sufficiently selective. Immunotherapy based treatment offers highly selective and efficient solution to this problem.
    A promising approach in Immunotherapy is adoptive cell therapy (ACT). In ACT, therapeutic lymphocytes are administrated to patients in order to treat a disease. In this process antibody-type cells are generated ex vivo, and then infused to the patient. By this technology the cells can be redirected against specific tumors via genetic engineering, using chimeric receptors.
    Currently ACT is logistically and economically challenging since it is limited by the used of the patients’ own cells. Another key concern is safety, due to the danger that the allogeneic cells will be rejected by the patient, or will attack the patient.
    In cancer, use of tumor specific, chimeric receptor redirected allogeneic T cells can transform ACT into a standardized, off-the shelf therapy. Overall this method proposes a safe and effective adoptive therapy using allogeneic cells while avoiding the use of bone marrow transplantation (BMT).

    Applications


    • Cancer immunotherapy

    Advantages


    • Off the shelf, standard treatment
    • Safe
    • Effective
    • No bone marrow transplantation (BMT) is required

    Technology's Essence


    A novel approach for adoptive immunotherapy using fully MHC-mismatch allogeneic T cells. These cells are redirected with tumor specific non-MHC-restricted antibody-based chimeric antigen receptor (T-bodies) in the absence of Graft-versus-host disease (GVHD). In order to create a standardize treatment, the redirection of T cells can be done through an antibody-based chimeric antigen receptor (CAR), thus creating ‘universal effector T cells’. This is based on a combination of of MHC-mismatched allogeneic T-cells with an MHC unrestricted chimeric antigen receptor. These cells would recognize their target independently of MHC restriction, therefore applied as an ‘off-the shelf’ immunotherapy. Regarding the second challenge of avoiding GVHD, by using a controlled lymphodepletion the researchers were able to create therapeutic window during which the allo-T-body cells could destroy the tumor before being themselves rejected.

    +
    • Prof. Zelig Eshhar

    Pages